Want to stay informed about updates on COVID-19 from qualified health care professionals? Join Darshan Kulkarni as he discusses who he follows on social media for news about the disease. From data scientists to clinical investigators, these...
Are pharmaceutical companies allowed to provide financial assistance for travel, lodging and other expenses to certain patients? Join FDA regulatory attorney Darshan Kulkarni as he discusses why the Office of Inspector General (OIG) decided in favor...
Transparency, or the practice of disclosing clinical trial data, is highly important in clinical research. What happens when companies decide to not publish all of their clinical trial results, and fall out of compliance with the FDAA? FDA...
In the wake of COVID-19, many companies have had to reshape how they conduct business. What is the role of the general counsel during this time? How should general counsel officers determine the ways in which COVID-19 may impact their businesses...
What are the four branches of patient centricity, and how can they apply to your company? In this episode, Darshan Kulkarni explains how companies can foster patient centricity through privacy, transparency, innovation and access. Plus, how the FDA...
Often, clinical trial results do not end up being disclosed. How can companies address this lack of transparency in clinical research? Darshan Kulkarni investigates the four ways in which health care companies can improve data transparency while...